NAUT Q4 2024 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

NAUTNautilus Biotechnology, Inc.

$339M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6M

Operating Income

-$20M

Net Income

-$18M

EPS (Diluted)

$-0.14

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$243M

Total Liabilities

$34M

Stockholders' Equity

$209M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6M	-$2M	-299.6%
Operating Income	-$20M	-$20M	+0.1%
Net Income	-$18M	-$17M	-3.3%